NTRK2 and leiomyosarcoma: Here, we showed the expression of TrkB and its ligands in human uterine leiomyosarcoma, and demonstrated an endogenous regulatory effect of TrkB on in vitro cell growth and survival using the soluble ectodomain of TrkB and a pan-Trk receptor inhibitor.